Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Jul;80(10):1599–1607. doi: 10.1038/sj.bjc.6690569

The increment of micronucleus frequency in cervical carcinoma during irradiation in vivo and its prognostic value for tumour radiocurability

M Widel 1, S Jędruś 2, S Owczarek 2, M Konopacka 1, B Lubecka 1, Z Kołosza 3
PMCID: PMC2363103  PMID: 10408406

Abstract

A potential usefulness of micronucleus assay for prediction of tumour radiosensitivity has been tested in 64 patients with advanced stage (II B–IV B) cervical carcinoma treated by radiotherapy. The study of cellular radiosensitivity in vitro was conducted in parallel with the study of cellular damage after tumour irradiation in vivo. Radiosensitivity of in vitro cultured primary cells isolated from tumour biopsies taken before radiotherapy was evaluated using cytokinesis-block micronucleus assay. Frequency of micronuclei per binucleated cell (MN/BNC) at 2 Gy was used as a measure of radiosensitivity. Radiation sensitivity in vivo was expressed as per cent increment of micronucleus frequency in cells isolated from biopsy taken after 20 Gy (external irradiation, 10 × 2 Gy) over the pre-treatment spontaneous micronucleus level and was called MN20. Very low correlation (r = 0.324) was observed between micronucleus frequency in vitro and in vivo. Although micronucleus frequency at 2 Gy differed widely between tumours evaluated (mean MN/BNC was 0.224; range 0.08–0.416), no significant correlation was observed between this parameter and clinical outcome. The average increment of micronucleus frequency after 20 Gy amounted to 193% of spontaneous level (range 60–610%) and was independent of spontaneous micronucleation before radiotherapy. In contrast to in vitro results, these from in vivo assay seem to have a predictive value for radiotherapy of cervix cancer. The micronucleus increment in vivo that reached at least 117.5% of pretreatment value (first quartile for MN20 data set) correlated significantly with better tumour local control (P < 0.008) and overall survival (P < 0.045). Our results suggest that evaluation of increment of micronucleus frequency during radiotherapy (after fixed tested dose of 20 Gy) offers a potentially valuable approach to predicting individual radioresponsiveness and may be helpful for individualization of treatment strategy in advanced stage cervical cancer. © 1999 Cancer Research Campaign

Keywords: cervical carcinoma, radiotherapy, micronucleus assay, predictive value

Full Text

The Full Text of this article is available as a PDF (141.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bakker P. J., Tukker L. J., Stap J., Veenhof C. H., Aten J. A. Micronuclei expression in tumors as a test for radiation sensitivity. Radiother Oncol. 1993 Jan;26(1):69–72. doi: 10.1016/0167-8140(93)90028-7. [DOI] [PubMed] [Google Scholar]
  2. Bush C., McMillan T. J. Micronucleus formation in human tumour cells: lack of correlation with radiosensitivity. Br J Cancer. 1993 Jan;67(1):102–106. doi: 10.1038/bjc.1993.17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Champion A. R., Hanson J. A., Court J. B., Venables S. E. The micronucleus assay: an evaluation of its use in determining radiosensitivity in vitro. Mutagenesis. 1995 May;10(3):203–208. doi: 10.1093/mutage/10.3.203. [DOI] [PubMed] [Google Scholar]
  4. Davidson S. E., West C. M., Roberts S. A., Hendry J. H., Hunter R. D. Radiosensitivity testing of primary cervical carcinoma: evaluation of intra- and inter-tumour heterogeneity. Radiother Oncol. 1990 Aug;18(4):349–356. doi: 10.1016/0167-8140(90)90115-d. [DOI] [PubMed] [Google Scholar]
  5. Girinsky T., Lubin R., Pignon J. P., Chavaudra N., Gazeau J., Dubray B., Cosset J. M., Socie G., Fertil B. Predictive value of in vitro radiosensitivity parameters in head and neck cancers and cervical carcinomas: preliminary correlations with local control and overall survival. Int J Radiat Oncol Biol Phys. 1993 Jan;25(1):3–7. doi: 10.1016/0360-3016(93)90137-k. [DOI] [PubMed] [Google Scholar]
  6. Heddle J. A., Carrano A. V. The DNA content of micronuclei induced in mouse bone marrow by gamma-irradiation: evidence that micronuclei arise from acentric chromosomal fragments. Mutat Res. 1977 Jul;44(1):63–69. doi: 10.1016/0027-5107(77)90115-4. [DOI] [PubMed] [Google Scholar]
  7. Johansen J., Streffer C., Fuhrmann C., Bentzen S. M., Stausbøl-Grøn B., Overgaard M., Overgaard J. Radiosensitivity of normal fibroblasts from breast cancer patients assessed by the micronucleus and colony assays. Int J Radiat Biol. 1998 Jun;73(6):671–678. doi: 10.1080/095530098141924. [DOI] [PubMed] [Google Scholar]
  8. Mariya Y., Streffer C., Fuhrmann C., Wojcik A. Correlation of radiation-induced micronucleus frequency with clonogenic survival in cells of one diploid and two tetraploid murine tumor cell lines of the same origin. Radiat Res. 1997 Jan;147(1):29–34. [PubMed] [Google Scholar]
  9. Midander J., Révész L. The frequency of micronuclei as a measure of cell survival in irradiated cell populations. Int J Radiat Biol Relat Stud Phys Chem Med. 1980 Aug;38(2):237–242. doi: 10.1080/09553008014551161. [DOI] [PubMed] [Google Scholar]
  10. Schwartz J. L., Mustafi R., Beckett M. A., Czyzewski E. A., Farhangi E., Grdina D. J., Rotmensch J., Weichselbaum R. R. Radiation-induced DNA double-strand break frequencies in human squamous cell carcinoma cell lines of different radiation sensitivities. Int J Radiat Biol. 1991 Jun;59(6):1341–1352. doi: 10.1080/09553009114551211. [DOI] [PubMed] [Google Scholar]
  11. Schwartz J. L., Mustafi R., Beckett M. A., Weichselbaum R. R. DNA double-strand break rejoining rates, inherent radiation sensitivity and human tumour response to radiotherapy. Br J Cancer. 1996 Jul;74(1):37–42. doi: 10.1038/bjc.1996.312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Shibamoto Y., Shibata T., Miyatake S., Oda Y., Manabe T., Ohshio G., Yagi K., Streffer C., Takahashi M., Abe M. Assessment of the proliferative activity and radiosensitivity of human tumours using the cytokinesis-block micronucleus assay. Br J Cancer. 1994 Jul;70(1):67–71. doi: 10.1038/bjc.1994.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Shibamoto Y., Streffer C., Fuhrmann C., Budach V. Tumor radiosensitivity prediction by the cytokinesis-block micronucleus assay. Radiat Res. 1991 Dec;128(3):293–300. [PubMed] [Google Scholar]
  14. Slavotinek A., McMillan T. J., Steel C. M. A comparison of micronucleus frequency and radiation survival in lymphoblastoid cell lines. Mutagenesis. 1993 Nov;8(6):569–575. doi: 10.1093/mutage/8.6.569. [DOI] [PubMed] [Google Scholar]
  15. Stap J., Aten J. A. Comparison of radiation sensitivity for three cell lines as measured by the cloning assay and the micro-nucleus test. Strahlenther Onkol. 1990 Nov;166(11):761–763. [PubMed] [Google Scholar]
  16. Villa R., Zaffaroni N., Gornati D., Costa A., Silvestrini R. Lack of a correlation between micronucleus formation and radiosensitivity in established and primary cultures of human tumours. Br J Cancer. 1994 Dec;70(6):1112–1117. doi: 10.1038/bjc.1994.457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wandl E. O., Ono K., Kain R., Herbsthofer T., Hienert G., Höbarth K. Linear correlation between surviving fraction and the micronucleus frequency. Int J Radiat Biol. 1989 Nov;56(5):771–775. doi: 10.1080/09553008914552031. [DOI] [PubMed] [Google Scholar]
  18. Weissenborn U., Streffer C. Micronuclei with kinetochores in human melanoma cells and rectal carcinomas. Int J Radiat Biol. 1991 Feb;59(2):373–383. doi: 10.1080/09553009114550341. [DOI] [PubMed] [Google Scholar]
  19. West C. M., Davidson S. E., Roberts S. A., Hunter R. D. Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix. Br J Cancer. 1993 Oct;68(4):819–823. doi: 10.1038/bjc.1993.434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. West C. M., Davidson S. E., Roberts S. A., Hunter R. D. The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix. Br J Cancer. 1997;76(9):1184–1190. doi: 10.1038/bjc.1997.531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. West C. M., Hendry J. H. Intrinsic radiosensitivity as a predictor of patient response to radiotherapy. BJR Suppl. 1992;24:146–152. [PubMed] [Google Scholar]
  22. Whitaker S. J., Ung Y. C., McMillan T. J. DNA double-strand break induction and rejoining as determinants of human tumour cell radiosensitivity. A pulsed-field gel electrophoresis study. Int J Radiat Biol. 1995 Jan;67(1):7–18. doi: 10.1080/09553009514550021. [DOI] [PubMed] [Google Scholar]
  23. Wideł M., Dobrut M., Maka B., Lubecka B., Pluciennik A. The radiosensitivity of human malignant melanomas evaluated by cytokinesis-block micronucleus assay. Neoplasma. 1997;44(2):109–116. [PubMed] [Google Scholar]
  24. Zölzer F., Alberti W., Pelzer T., Lamberti G., Hülskamp F. H., Streffer C. Changes in S-phase fraction and micronucleus frequency as prognostic factors in radiotherapy of cervical carcinoma. Radiother Oncol. 1995 Aug;36(2):128–132. doi: 10.1016/0167-8140(95)01601-c. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES